Make your money go further for just 25p per day


Coronavirus: potential winners from the almost-pandemic

Coronavirus microscopic image

If there is one positive from the outbreak of the coronavirus – which has spread alarmingly quickly since it first emerged in China at the end of last year – it is that global healthcare systems have been alerted to the need for better contamination control.

It’s hardly surprising therefore, that the share price of Tristel (LON: TSTL), a specialist manufacturer of infection prevention and contamination control products, has climbed to new highs over recent weeks. It could be a big long-term winner from greater investment in global infection prevention.

Tristel’s proprietary chlorine dioxide formulation was first developed in 1993 for the disinfection of flexible endoscopes, replacing then-gold-standard glutaraldehyde, a substance known to be toxic. Originally used in water treatment and food…

Sign up and read the full article

Register to continue reading our content.

Get FREE access now

Already a member? Login

Fundamental Asset Management
Buy any of our portfolios with our associates.


Previous article Next article

Have your say

Log in or register to view or add comments.

For access to the top news and insights from the investment world


Become a Champion Investor for just £90 a year.


More on Tristel

AstraZeneca vs GlaxoSmithKline: a clear coronavirus winner?

31/07/2020 · Company Insights

The pharmaceutical industry has enjoyed a strong 2020. These are companies which – in the eyes…

Coronavirus impact: 22 July part 2 - pandemic winner offers overly cautious outlook

22/07/2020 · Company Insights

Shareholders have been taking profit from beneficiaries of the pandemic and there are concerns of a more challenging…

More Company Insights

Coronavirus impact: 18 Sept – automotive testing specialist remains in good shape

A retail giant with a big new opportunity

18/09/2020 · Tesco

Coronavirus impact: 17 Sept - stunning results from a Covid tester